-
New NIH Analysis Links PFAS ‘Forever Chemicals’ to Increased Aggressive Breast Cancer Risk
Understanding the Link Between PFAS and Breast Cancer A recent analysis conducted by the National Institutes of Health (NIH) has shed light on a concerning potential health risk regarding PFAS (per- and polyfluoroalkyl substances), often referred to as ‘forever chemicals.’ These synthetic substances, known for their persistence in the environment and the human body, have…
-
Unlocking the Code of Neurodegeneration: Stowers Scientist Joins $28.6 Million Research Initiative
A New Frontier in Brain Health Neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, remain some of the most complex challenges in modern medicine. A significant new development has emerged from the Stowers Institute for Medical Research, where scientist Jeffrey J. Pleiss, Ph.D., has been selected to participate in a massive, multi-institutional research effort. The $28.6…
-
New Hope for Alpha-gal Syndrome: NIH Researchers Discover Rare Antibodies
A Breakthrough in Allergy Research For those living with Alpha-gal syndrome (AGS)—a life-altering condition that triggers severe allergic reactions to red meat and other products derived from mammals—the path forward may be getting clearer. Researchers at the National Institutes of Health (NIH) have recently identified a unique set of rare antibodies that could change how…
-
New NIH Research Paves the Way for Experimental Opioid Use Disorder Treatment
A Breakthrough in Addiction Research The National Institutes of Health (NIH) has announced a significant milestone in the fight against the opioid epidemic. Recent findings from the National Institute on Drug Abuse (NIDA) have cleared the path for a new clinical trial focused on evaluating an experimental treatment for opioid use disorder (OUD). Why This…